Science Explorer Back to mapMap
Discussion
Company · Tübingen · Germany

Synimmune (Germany)

synimmune.de/welcomeROR OpenAlex
Research works
3
▼ 78% vs 2018-21
Citations
53
16.8 per fractional work
Top-10% rate
2.4%
all institutions 10.0%
Open access
41%
world 40%
International
26%
world 18%
Synimmune (Germany)

Not ranked overall: Synimmune (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Synimmune (Germany) work in?

In all years, 50% of research at Synimmune (Germany) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (50%), Biochemistry, Genetics and Molecular Biology (28%), Immunology and Microbiology (9%).

Health Sciences: 2 fractional works · 50.0% of its workMedicine: 2 fractional works · 50.0% of its workLife Sciences: 1 fractional works · 37.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 28.1% of its workImmunology and Microbiology: 0 fractional works · 9.4% of its workPhysical Sciences: 0 fractional works · 12.5% of its workChemistry: 0 fractional works · 6.2% of its workEngineering: 0 fractional works · 3.1% of its workPhysics and Astronomy: 0 fractional works · 3.1% of its workALL ITS WORKSynimmune(Germany)3fractional works, all years
Life Sciences38%Physical Sciences12%Health Sciences50%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Medicine250.0%
    1. Biochemistry, Genetics and Molecular Biology128.1%
    2. Immunology and Microbiology09.4%
    1. Chemistry06.2%
    2. Engineering03.1%
    3. Physics and Astronomy03.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from Synimmune (Germany)?

The most cited paper from Synimmune (Germany) is "Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth" (Sarah Oelsner, Anja Waldmann, Arne Billmeier et al., 2019), with 87 citations. Next come "Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia" (57) and "γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay" (48).

Most cited papers
#PaperReleasedCitations
1 Genetically engineered CAR NK cells display selective cytotoxicity against FLT3‐positive B‐ALL and inhibit in vivo leukemia growth Sarah Oelsner, Anja Waldmann, Arne Billmeier et al. · International Journal of Cancer 12 Mar 2019 87
2 Characterization of a Bispecific FLT3 X CD3 Antibody in an Improved, Recombinant Format for the Treatment of Leukemia Michael Durben, Dominik Schmiedel, Martin Hofmann et al. · Molecular Therapy Open access 12 Jan 2015 57
3 γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay Ursula Jördis Eva Seidel, Fabian Vogt, Ludger Große‐Hovest et al. · Frontiers in Immunology Open access 2 Dec 2014 48
4 Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody Ursula Jördis Eva Seidel, Patrick Schlegel, Ludger Große‐Hovest et al. · Molecular Therapy Open access 6 Jul 2016 21
5 Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease Jonas S. Heitmann, Richard F. Schlenk, Daniela Dörfel et al. · Journal of Hematology & Oncology Open access 17 Aug 2023 17
All 15 most cited papers, with filters and sorting

Which research topics does Synimmune (Germany) publish most on?

By volume in 2022-now: RNA and protein synthesis mechanisms, Advanced biosensing and bioanalysis techniques, Force Microscopy Techniques and Applications and Acute Myeloid Leukemia Research.

RNA and protein synthesi…0RNA and protein synthesis mechanisms: 0 fractional worksAdvanced biosensing and …0Advanced biosensing and bioanalysis techniques: 0 fractional worksForce Microscopy Techniq…0Force Microscopy Techniques and Applications: 0 fractional works
Molecular BiologyAtomic and Molecular Physics, and Optics

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 RNA and protein synthesis mechanisms Molecular Biology 0 works
  2. 2 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  3. 3 Force Microscopy Techniques and Applications Atomic and Molecular Physics, and Optics 0 works
  4. 4 Acute Myeloid Leukemia Research Hematology 0 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Hematopoietic Stem Cell Transplantation Hematology 0 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 CAR-T cell therapy research Oncology 0 works
  9. 9 Heat shock proteins research Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.3%not open58.7%

World: 40% of research is openly available.

with international co-authors26.5%domestic only73.5%

World: 18% is written across borders.

How has Synimmune (Germany)'s research output changed?

Output in 2022-2025 was 78% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tübingen

All research institutions in Tübingen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Synimmune (Germany). Posts are plain text and can be reported.